Protecting the immunosuppressed from COVID-19
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA400335
Grant search
Key facts
Disease
COVID-19Start & end year
20252029Known Financial Commitments (USD)
$419,464.66Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
University of New South WalesResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Policy research and interventions
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Through either vaccination or infection, most people now possess some degree of immune protection from COVID-19. However, nearly 2 in 10 people in Australia have some degree of immunosuppression which can leave them susceptible to severe COVID-19. This project aims to link clinical and laboratory data to identify at-risk individuals, develop strategies for the optimal use of vaccines and treatments to protect them from COVID-19, and to inform treatment guidelines to protect the most vulnerable.